Stock BVX BIVICTRIX THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BiVictriX Therapeutics Plc

Equities

BVX

GB00BNXH3K91

Market Closed - London S.E.
Other stock markets
 16:35:20 09/05/2024 BST 		5-day change 1st Jan Change
11.5 GBX 0.00% Intraday chart for BiVictriX Therapeutics Plc 0.00% +9.52%
04-17 Bivictrix granted FDA orphan drug status for rare cancer treatment AN
04-17 BiVictriX Wins US FDA's Orphan Drug Status for Blood Cancer Treatment MT

Evolution of the average Target Price on BiVictriX Therapeutics Plc

Price target over the last 5 years

History of analyst recommendation changes

1d6bc642.hxjLx1AsWnpsXTBe3VUe2f0-MQ9_tvE9cAvwCZiVTW0.7E2OjhJfKC0oEggYlTNpmLtKQ0ER3qVsNTqFQujKGCfLXbuFfU0ONAkLdQ~311000ce1f835778648edabef810bae9

Analyst Recommendations on BiVictriX Therapeutics Plc

Bivictrix says BVX001 increases survival rates by more than double AN
BiVictriX Therapeutics' Blood Cancer Drug Delivers Extended Survival Rates in Trial MT
Bivictrix Therapeutics PLC Extended Survival Rates Reported With Bvx001 In A Pre-Clinical Model Of Acute Myeloid Leukaemia RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.115 GBP
Average target price
0.66 GBP
Spread / Average Target
+473.91%
High Price Target
0.66 GBP
Spread / Highest target
+473.91%
Low Price Target
0.66 GBP
Spread / Lowest Target
+473.91%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BVX Stock
  4. Consensus BiVictriX Therapeutics Plc